Measuring transparency to improve good governance in the public pharmaceutical sector Jordan

• Pubblicazione: Cairo, Egypt, : World Health Organization, Regional Office for the Eastern Mediterranean, c2009
• Edizione: 1st ed.
• Descrizione fisica: 1 online resource (70 p.)
• Disciplina: 615.19
• Soggetto topico: Pharmaceutical industry - Standards - Jordan; Pharmaceutical policy - Jordan
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references.
• Nota di contenuto: COVER; TITLE; COPYRIGHT; Contents; Foreword; 7 Preface; Acknowledgements; Executive summary; 1. Introduction; 2. Overview of the public pharmaceutical sector in Jordan; 3. Methodology; 4. Results; 5. Data analysis and interpretation; 6. Recommendations; 7. Conclusions; Annexes
• Sommario/riassunto: In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the gove
• Altri titoli varianti: Jordan
• Titolo autorizzato: Measuring transparency to improve good governance in the public pharmaceutical sector
• ISBN: 1-282-76098-X; 9786612760983; 92-9021-682-4
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910826620503321
• Lo trovi qui: Univ. Federico II